All Stories

  1. Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients

    Article • November 2019, Taylor & Francis

    MD, PhD Jozsef Attila Szasz, LIGIA BANCU, Szabolcs Szatmari

  2. Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients

    Article • April 2019, Dove Medical Press

    Szabolcs Szatmari, MD, PhD Jozsef Attila Szasz

  3. Characteristics of levodopa treatment in advanced Parkinson’s disease

    Article • Orvosi Hetilap, April 2019, Akademiai Kiado

    Szabolcs Szatmari, MD, PhD Jozsef Attila Szasz

  4. DOPAMINE AGONISTS IN PARKINSON’S DISEASE THERAPY – 15 YEARS OF EXPERIENCE

    Article • Ideggyógyászati Szemle, January 2019, Ideggyogyaszati Szemle Journal

    MD, PhD Jozsef Attila Szasz, Szabolcs Szatmari

  5. Selective monoamine oxidase B inhibitors for Parkinson's disease in Tirgu Mures, Romania

    Article • Orvosi Hetilap, December 2017, Akademiai Kiado

    Szabolcs Szatmari, MD, PhD Jozsef Attila Szasz

  6. Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

    Article • Parkinsonism & Related Disorders, December 2017, Elsevier

    MD, PhD Jozsef Attila Szasz

  7. The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience

    Article • Journal of Neural Transmission, December 2015, Springer Science + Business Media

    MD, PhD Jozsef Attila Szasz

  8. Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease

    Article • Movement Disorders, July 2014, Wiley

    MD, PhD Jozsef Attila Szasz

  9. Prestroke Alcohol Consumption and Smoking Are Not Associated with Stroke Severity, Disability at Discharge, and Case Fatality

    Article • Journal of Stroke and Cerebrovascular Diseases, January 2014, Elsevier

    MD, PhD Jozsef Attila Szasz, Szabolcs Szatmari

  10. Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

    Article • Movement Disorders, December 2013, Wiley

    MD, PhD Jozsef Attila Szasz

  11. Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison

    Article • European Journal of Neurology, November 2006, Wiley

    MD, PhD Jozsef Attila Szasz, Szabolcs Szatmari

  12. The Mures-Uzhgorod-Debrecen study: a comparison of hospital stroke services in Central-Eastern Europe

    Article • European Journal of Neurology, May 2002, Wiley

    MD, PhD Jozsef Attila Szasz, Szabolcs Szatmari